S33 Towards Identification of Molecular Mechanisms of Idiopathic Short Stature

Program: Symposia
Clinical/Translational Session
Friday, March 6, 2015: 9:30 AM-11:00 AM
Room 33 (San Diego Convention Center)
**This session is eligible for CME credit**

Supported by Novo Nordisk Inc.

Ron G Rosenfeld, M.D., Stat 5 LLC, Los Altos, CA

Nothing to Disclose: RGR Disclosure Not Provided: TMF, VH, JS

Advances in genomic technologies are revolutionizing the diagnostic approach to short stature. Endocrinologists must become facile with the use of molecular testing in order to identify various genetic disorders that present with short stature. Techniques that will be discussed include GWAS, candidate gene analysis, whole exome or whole genome scanning, and microarrays.

9:30 AM
Pinchas Cohen, USC Leonard Davis School of Gerontology, University of Southern California, Los Angeles, CA
Disclosure: PC: Advisory Group Member, Ascendis, Advisory Group Member, Opko, Advisory Group Member, Versartis, Advisory Group Member, Teva.
10:00 AM
Andrew Dauber, MD, Division of Endocrinology, Cincinnati Center for Growth Disorders, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Nothing to Disclose: AD
10:30 AM
Dennis Jay Chia, MD, Pediatric Endocrinology, Mount Sinai School of Medicine, New York, NY
Disclosure: DJC: Principal Investigator, Genentech, Inc..
See more of: Symposia